Chrissy Burton | Senior Director Clinical Operations
BridgeBio Gene Therapy

Chrissy Burton is a results-driven Senior Director of Clinical Operations at BridgeBio Gene Therapy, with a proven track record of leading successful clinical trials globally in the biopharmaceutical industry. With over 15 years of experience in drug development and over 20 years as am RN with primary patient focus in Critical Care, Chrissy is a strategic thinker known for her expertise in optimizing operational efficiencies and driving innovation in clinical research.

Chrissy's strong leadership skills and collaborative approach have enabled her to build and lead high-performing teams, ensuring the successful execution of complex clinical programs. She is passionate about advancing gene therapy research and bringing life-changing treatments to patients in need.

At the World Drug Safety Congress Americas 2025, Chrissy will share her insights on leveraging innovation, technology, and performance to enhance safety practices in drug development. Her session will provide valuable perspectives for safety professionals and partners looking to optimize their processes and drive excellence in pharmacovigilance.

With a deep understanding of regulatory requirements and a commitment to patient safety, Chrissy Burton is a respected industry expert who continues to make significant contributions to the field of drug safety and clinical operations. Attendees can expect to gain valuable knowledge and practical strategies from Chrissy's presentation at the conference.

Appearances:

Day 2 - World Drug Safety Congress Americas @ 11:35

Fireside Chat: Patient Recruitment in Drug Safety

Mitra Tavakkoli, Executive Medical Lead, BridgeBio Gene Therapy

Chrissy Burton, Senior Director Clinical Operations, BridgeBio Gene Therapy

Alicia Gomez, Social Work Coordinator Consultant, BridgeBio Gene Therapy

Day 2 - World Drug Safety Congress Americas @ 11:55

Panel: Rebuilding Safety Around the Patient: Moving Medical Safety Beyond the Silo and Back to the Bedside

In an era of increasing complexity in drug development and real-world use, patient safety must be re-centered as a multidisciplinary, patient-facing function - not just a regulatory requirement. This panel, Rebuilding Safety Around the Patient: Moving Medical Safety Beyond the Silo and Back to the Bedside, explores how safety science can evolve beyond traditional silos to actively engage with patients, clinicians, and data at the point of care. Panelists will share practical strategies for bridging the gap between pharmacovigilance and patient experience through cross-functional collaboration, patient-reported outcomes, and ethical transparency. Join us for a thought-provoking discussion on reimagining medical safety as a bedside ally rather than a back-office function.

Moderator: Anuj Parikh MD FACEP, Associate Medical Director, Jazz Pharmaceuticals